Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 September 1997:
Vol. 277. no. 5333, pp. 1752 - 1753
DOI: 10.1126/science.277.5333.1752
Prev | Table of Contents | Next

News & Comment

ECONOMICS:
Snipping Away at Genome Patenting

Eliot Marshall

Genetic markers called single nucleotide polymorphisms (SNPs or "snips") are becoming a hot commercial property. They offer unique and efficient signposts that can be used by researchers scanning an entire genome for significant mutations, and they are piling up in growing numbers as public and private institutions churn out more and more human DNA sequence data. But some companies--and, according to rumors, some research groups--are staking proprietary claims on SNPs. Last week, a group of researchers urged the National Institutes of Health to undermine such claims by creating a public repository of SNPs. They got a sympathetic response from Human Genome Project chief Francis Collins.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Overlapping Genomic Sequences: A Treasure Trove of Single-Nucleotide Polymorphisms.
P. Taillon-Miller, Z. Gu, Q. Li, L. Hillier, and P.-Y. Kwok (1998)
Genome Res. 8, 748-754
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)